Tuesday, June 25, 2024
HomeUSABMO Capital Markets says this biotech company is 'best-in-class,' sees shares surging...

BMO Capital Markets says this biotech company is ‘best-in-class,’ sees shares surging more than 25%

Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments